Equities researchers at Zacks Research upped their Q3 2025 earnings per share estimates for shares of Vertex Pharmaceuticals ...

This was the stock's fourth consecutive day of gains.

JMP Securities raised the firm’s price target on Rhythm Pharmaceuticals (RYTM) to $75 from $64 and keeps an Outperform rating on the shares as part of a broader note on Biotechnology.

December 27, 2024 • Wellpath, a health care provider for hospitals, prisons and jails, has been dogged by wrongful death and medical negligence suits. What happens to those cases now that it has ...

1,487 years ago today, the Hagia Sophia was completed. The Eastern Orthodox Church of Holy Wisdom is considered the greatest Byzantine building. It was ...